MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.880
-0.250 (-6.05%)
At close: Jun 16, 2026, 4:00 PM EDT
3.900
+0.020 (0.52%)
After-hours: Jun 16, 2026, 7:13 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $246.31 million as of June 16, 2026. Its market cap has increased by 180.85% in one year.
Market Cap
246.31M
Enterprise Value
129.54M
1-Year Change
180.85%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $246.31M, a decrease of -58.97%. That is a compound annual growth rate of -6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 246.31M | 141.95% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 271.57M |
| Immuneering | 271.08M |
| Zentalis Pharmaceuticals | 266.95M |
| Orchestra BioMed Holdings | 245.51M |
| Foghorn Therapeutics | 245.42M |
| Fate Therapeutics | 240.11M |
| Sol-Gel Technologies | 240.07M |
| Adagene | 235.88M |